Schlessinger D
Department of Microbiology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110.
Clin Microbiol Rev. 1988 Jan;1(1):54-9. doi: 10.1128/CMR.1.1.54.
The critical inhibition of ribosome function by aminoglycosides has long been established. But the binding of drug to ribosomes is reversible: why then are aminoglycosides bactericidal? Several groups have shown that irreversible action (lethality) results from irreversible uptake into susceptible cells; conversely, resistance in cases such as anaerobiosis is associated with the failure of uptake. Oddly, the pattern of results excludes all traditional transport mechanisms; most unusual is the apparent dependence of uptake on the interaction of drug with ribosomes. A traditional view that ribosomes may function during uptake as a "sink" for aminoglycosides cannot explain all the data. Instead, the alternative is considered that cycling ribosomes at the cell membrane help to induce "one-way endocytic pores." Although no detailed mechanism is formulated, the results do suggest a way that the permeation of antibiotics might be systematically controllable to render them more cidal.
氨基糖苷类药物对核糖体功能的关键抑制作用早已得到证实。但药物与核糖体的结合是可逆的:那么为什么氨基糖苷类药物具有杀菌作用呢?几个研究小组表明,不可逆作用(致死性)源于药物不可逆地进入敏感细胞;相反,在诸如厌氧菌感染等情况下的耐药性与药物摄取失败有关。奇怪的是,这些结果模式排除了所有传统的转运机制;最不寻常的是,摄取明显依赖于药物与核糖体的相互作用。核糖体在摄取过程中可能作为氨基糖苷类药物的“汇”发挥作用这一传统观点无法解释所有数据。相反,有人提出另一种观点,即细胞膜上循环的核糖体有助于诱导“单向内吞孔”。虽然没有制定详细的机制,但这些结果确实提示了一种使抗生素渗透得以系统控制从而使其更具杀菌性的方法。